Literature DB >> 12943181

Suppressing tumor progression of in vitro prostate cancer cells by emitted psychosomatic power through Zen meditation.

Tiing Yu1, Hui Ling Tsai, Ming Liang Hwang.   

Abstract

Human prostate cancer PC3 cells were treated in vitro with psychosomatic power emitted by a Buddhist-Zen Master. A significant decrease of growth rate was observed as determined by MTT assay after 48 hours. These cells also had two- to three-fold higher levels of prostatic acid phosphatase (PAcP) activity, a prostate tissue-specific differentiation antigen. In addition, the treated cells formed fewer and smaller colonies in soft agar as compared with control cells, which displayed anchorage-independent growth. These observations provide insight into the suppressive effects of healing power through the practice of Buddhist-Zen meditation on tumor progression. The emitted bioenergy may be suggested as an alternative and feasible approach for cancer research and patient treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943181     DOI: 10.1142/S0192415X03001132

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

1.  Alternative medicine techniques have non-linear effects on radiation response and can alter the expression of radiation induced bystander effects.

Authors:  Carmel Mothersill; Richard Smith; Matthew Henry; Colin Seymour; Raimond Wong
Journal:  Dose Response       Date:  2012-01-20       Impact factor: 2.658

2.  Spatially Nonlinear Interdependence of Alpha-Oscillatory Neural Networks under Chan Meditation.

Authors:  Pei-Chen Lo; Chih-Hao Chang
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-17       Impact factor: 2.629

3.  Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis.

Authors:  Alice Running; Mark Greenwood; Laura Hildreth; Jade Schmidt
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-05       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.